← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2017Last known activity
Oct 31, 2024
Timeline
2010s
- Jul 9, 2012
Sclnow Biotechnology Co., Ltd.— Founded
Drugs by trial phase (4 distinct, 14 trials)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
- Ataxia
- Cerebellar Ataxia
- Cerebral Infarction
- Femur Head Necrosis
- Fibrosis
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis B
- Infarction
- Liver Cirrhosis
- Machado-Joseph Disease
- Menopause, Premature
- Myelodysplastic Syndromes
- Osteoarthritis
- Osteoarthritis, Knee
- Osteonecrosis
- Preleukemia
- Premature Birth
- Primary Ovarian Insufficiency
- Spinocerebellar Ataxias
- Spinocerebellar Degenerations
- Syndrome
- Wounds and Injuries
Recent trials (14)
- NCT06589271Lead sponsorPhase 1Oct 31, 2024
- NCT06503471Lead sponsorPhase 1Aug 31, 2024
- NCT05495711Lead sponsorPhase 1May 1, 2020
- NCT04104412Lead sponsorPhase 1Aug 15, 2019
- NCT03826433Lead sponsorPhase 1Oct 1, 2018
- NCT03816852Lead sponsorPhase 2Oct 1, 2018
- NCT03383081Lead sponsorPhase 2Jan 31, 2018
- NCT03386708Lead sponsorPhase 2Jan 31, 2018
- NCT03378414Lead sponsorPhase 2Jan 31, 2018
- NCT03180450Lead sponsorPhase 1/Phase 2Jul 1, 2017
- NCT03186456Lead sponsorPhase 1Jul 1, 2017
- NCT03180463Lead sponsorPhase 1/Phase 2Jul 1, 2017
- NCT03184935Lead sponsorPhase 1/Phase 2Jul 1, 2017
- NCT03176498Lead sponsorPhase 1/Phase 2Jul 1, 2017
Details
- Founded
- Beijing, CN Jul 9, 2012
- Last known activity
- Oct 31, 2024